Sana Biotechnology Income Statement 2019-2025 | SANA

Revenue

Cost Of Goods Sold

Gross Profit

Research And Development Expenses

$219.842

$201.003

$306.499

$257.879

$119.375

SG&A Expenses

$73.299

$71.561

$50.41

$28.27

$21.777

Other Operating Income Or Expenses

Operating Expenses

Operating Income

$-293.141

$-272.564

$-356.909

$-286.149

$-141.152

Total Non-Operating Income/Expense

$9.886

$3.088

$0.981

$0.844

$2.827

Pre-Tax Income

$-283.255

$-269.476

$-355.928

$-285.305

$-138.325

Income Taxes

$-7.547

Income After Taxes

$-283.255

$-269.476

$-355.928

$-285.305

$-130.778

Other Income

Income From Continuous Operations

$-283.255

$-269.476

$-355.928

$-285.305

$-130.778

Income From Discontinued Operations

Net Income

$-283.255

$-269.476

$-355.928

$-285.305

$-130.778

EBITDA

$-268.584

$-256.939

$-345.839

$-280.228

$-139.326

EBIT

$-293.141

$-272.564

$-356.909

$-286.149

$-141.152

Basic Shares Outstanding

195

188

166

Shares Outstanding

195

188

166

Basic EPS

$-1.46

$-1.43

$-2.14

$-21.92

$-26.68

EPS - Earnings Per Share

$-1.46

$-1.43

$-2.14

$-21.92

$-26.68